| 2026-10-06 09:11 |
8-K |
["2.01"] |
merger agreement |
1.00
|
Merger between BioLife Solutions and Repligen completed on October 6, 2026. |
SEC · detail |
| 2026-09-09 17:21 |
8-K |
["8.01"] |
merger agreement |
0.98
|
Definitive merger agreement: Repligen to acquire BioLife for $11.25 cash + 0.1442 shares/share; HSR clearance obtained, stockholder vote scheduled October 5, 2026. |
SEC · detail |
| 2026-09-04 17:23 |
DEFM14A |
|
merger agreement |
0.98
|
Definitive merger agreement: Repligen to acquire BioLife Solutions for stock + cash; stockholder vote scheduled October 5, 2026. |
SEC · detail |
| 2026-08-03 17:15 |
8-K |
["7.01", "9.01"] |
merger agreement |
0.98
|
Definitive merger agreement between BioLife (BLFS) and Repligen (RGEN) signed July 21, 2026, with employee communications circulated. |
SEC · detail |
| 2026-07-22 17:17 |
8-K |
["1.01"] |
merger agreement |
0.98
|
BioLife Solutions entered definitive merger agreement with Repligen for $11.25 cash + 0.1442 stock per share. |
SEC · detail |
| 2026-06-03 08:03 |
8-K |
["7.01", "9.01"] |
other |
0.05
|
Routine investor presentation disclosure for Jefferies Global Healthcare Conference; no M&A signals. |
SEC · detail |